Risk factors associated with initiation of a biologic disease modifying anti-rheumatic drug in patients with rheumatoid arthritis: A nested case-control study on 34,925 patients

Park Eun Hye; Shin Anna; Ha You-Jung; Lee Yun Jong; Lee Eun Bong; Song Yeong Wook; Kang Eun Ha

首页> 外文期刊>Joint, bone, spine : >Risk factors associated with initiation of a biologic disease modifying anti-rheumatic drug in patients with rheumatoid arthritis: A nested case-control study on 34,925 patients

【24h】

Risk factors associated with initiation of a biologic disease modifying anti-rheumatic drug in patients with rheumatoid arthritis: A nested case-control study on 34,925 patients

机译：与类风湿性关节炎患者改性抗风湿药物的生物疾病启动相关的危险因素：嵌套案例对照研究34,925名患者

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To identify risk factors of biological disease-modifying anti-rheumatic drugs (bDMARDs) initiation in patients with rheumatoid arthritis (RA).

机译：目的：确定类风湿关节炎（RA）患者服用生物性疾病修饰抗风湿药物（bDMARDs）的危险因素。

著录项

来源
《Joint, bone, spine :》 |2021年第1期|共8页
作者
Park Eun Hye; Shin Anna; Ha You-Jung; Lee Yun Jong; Lee Eun Bong; Song Yeong Wook; Kang Eun Ha;
展开▼
作者单位

Seoul Natl Univ Bundang Hosp Dept Internal Med Div Rheumatol Seongnam South Korea;

Seoul Natl Univ Bundang Hosp Dept Internal Med Div Rheumatol Seongnam South Korea;

Seoul Natl Univ Bundang Hosp Dept Internal Med Div Rheumatol Seongnam South Korea;

Seoul Natl Univ Bundang Hosp Dept Internal Med Div Rheumatol Seongnam South Korea;

Seoul Natl Univ Hosp Dept Internal Med Div Rheumatol Seoul South Korea;

Seoul Natl Univ Hosp Dept Internal Med Div Rheumatol Seoul South Korea;

Seoul Natl Univ Bundang Hosp Dept Internal Med Div Rheumatol Seongnam South Korea;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学各论;
关键词
Rheumatoid arthritis; Biologic disease-modifying drugs; Predictors;

机译：类风湿性关节炎;生物学疾病改性药物;预测因子;

相似文献

外文文献
中文文献
专利

1. Effect of sustained intensive therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis: a 5-year real-world consecutive study [J] . Yue-Ming Cai, Jing Xu, Lian-Jie Shi, 中华医学杂志（英文版） . 2020,第012期
2. Risk factors for losing hepatitis B virus surface antibody in patients with HBV surface antigen negative/surface antibody positive serostatus receiving biologic disease-modifying anti-rheumatic drugs: a nested case-control study [J] . Hung Ming-Hui, Tien Ya-Chih, Chiu Ying-Ming Advances in Rheumatology . 2021,第a期

机译：危险因素用于患有HBV表面抗原阴性/表面抗体阳性血清患者接受生物疾病改性抗风湿药物的患者患者的乙型肝炎病毒表面抗体：嵌套病例对照研究
3. Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study [J] . Nik-Madihah Nik-Azis, Nurulhuda Mohd, Fazalina Mohd Fadzilah, PLoS One . 2021,第6期

机译：牙周炎患者的类风湿性关节炎血清型和合成疾病改性抗风湿药物：一个案例对照研究
4. Association between Bone Mineral Density of Femoral Neck and Geriatric Nutritional Risk Index in Rheumatoid Arthritis Patients Treated with Biological Disease-Modifying Anti-Rheumatic Drugs [J] . Hiroto Tokumoto, Hiroyuki Tominaga, Yoshiya Arishima, Nutrients . 2018,第2期

机译：改良生物病抗风湿药治疗的类风湿关节炎患者股骨颈骨密度与老年营养风险指数的关系
5. Deep radiomic prediction with clinical predictors of the survival in patients with rheumatoid arthritis-associated interstitial lung diseases [C] . Radin A. Nasirudin, Janne J. Nappi, Chinatsu Watari, SPIE Medical Imaging Conference . 2018

机译：类风湿关节炎相关性间质性肺疾病患者的深部放射学预测和生存期的临床预测
6. “Don’t Rock the Boat”: A Qualitative Narrative Study Exploring Rheumatoid Arthritis Patients’ Experience of Illness and Biologics [D] . Rachich, Meagan . 2020

机译：“不要摇滚船”：探索类风湿性关节炎患者的疾病和生物学经验的定性叙事研究
7. The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab Abatacept and Tociliziumab [O] . Sella Aarrestad Provan, Inger Jorid Berg, Hilde Berner Hammer, -1

机译：新型抗风湿药生物疾病改良药物对心血管危险因素的影响：利妥昔单抗阿巴西普和Tociliziumab治疗的类风湿关节炎患者为期12个月的纵向研究
8. The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab. [O] . Sella Aarrestad Provan, Inger Jorid Berg, Hilde Berner Hammer, 2015

机译：更新生物疾病改变抗风湿药物对心血管危险因素的影响：利妥昔单抗，阿巴西普和Tociliziumab治疗类风湿性关节炎患者的12个月纵向研究。
9. Assessing Medication Adherence in Patients with Rheumatoid Arthritis (RA). [R] . Sumner, S. M. 2017

机译：评估类风湿性关节炎（Ra）患者的药物依从性。

Risk factors associated with initiation of a biologic disease modifying anti-rheumatic drug in patients with rheumatoid arthritis: A nested case-control study on 34,925 patients

摘要

著录项

相似文献

相关主题

期刊订阅